Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2025-12-24 @ 5:12 PM
NCT ID:
NCT04273750
Eligibility Criteria:
Inclusion Criteria:
* Subjects capable of giving informed consent, or in case of lack of capacity, their legal representative consent on their behalf.
* Older than 18 years old and younger than 80 years old.
* Diagnosis of cirrhosis according to liver biopsy, or non-invasive markers (Fibroscan) or a combination of clinical and imaging criteria.
* Diagnosis of AKI stage 2-3 or stage 1 with serum Creatinine \> 133 µmol/L, according to the last international consensus (International Club of Ascites, 2015)
Exclusion Criteria:
* Advanced hepatocellular carcinoma, Barcelona-Clinic liver cancer (BCLC) stage C or D
* Infection by human immunodeficiency virus (HIV)
* Previous transplant or any other type of immunodeficiency
* Pregnancy
* Long-term treatment with steroids or other immunosuppressive agents or interferon
* Severe chronic heart failure, New York Heart Association (NYHA), class III or IV
* Advanced COPD, global initiative for chronic obstructive lung disease (GOLD) III or IV
* Renal failure on haemodialysis
* Any medical condition that gives a survival shorter than 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04273750
Study Brief:
Protocol Section:
NCT04273750